T1	Participants 67 104	patients with high serum MMP-8 levels
T2	Participants 421 462	460 patients with stage IIB-IIIC melanoma
T3	Participants 1032 1056	patients with high MMP-8
T4	Participants 1584 1621	patients with high serum MMP-8 levels
